MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.

Slides:



Advertisements
Similar presentations
Introduction to NUTRITION
Advertisements

WHY USE ANIMALS?  Human beings use animals for a wide variety of purposes  260 million people in the US have pets  More than 5 billion animals are consumed.
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
Chemical Carcinogens – workplace risk assessment and health surveillance Tiina Santonen Paide.
Risk Assessment.
CHEMICAL CARCINOGENS CHEMICAL CARCINOGENS. What is a Chemical Carcinogen?  Any chemical compound which has been shown to cause cancer in humans or in.
CONFERENCE ON “ FOOD ADDITIVES : SAFETY IN USE AND CONSUMER CONCERNS“ JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY NAIROBI, 24 JUNE 2014.
Emissions Transport and Fate Concentrations Exposure Dose Dose-response Relationship Health Risk Schematic overview of a Health Risk Assessment.
Chapters 9 & 10: V itamins. © 2010 Pearson Education, Inc. Vitamins  Tasteless, organic compounds  Required in small amounts  Functions Regulate metabolism.
NSF/ANSI STANDARD 61 FRAMEWORK FOR RISK ASSESSMENTS For use by Toxicology Sub-committee only Please do not copy or distribute.
NUTRITION.
What Do Toxicologists Do?
Risk Assessment II Dec 9, Is there a “safe” dose ? For effects other than cancer:
Preclinical – Animal Study
Toxicology please grab a notes sheet. Toxicology: the study of the adverse effects of chemicals on health. Toxicity: how harmful something is. Depends.
Why Risk Analysis?  General public concern over real or imaged food- borne hazards to health  Recognition of the absence of systematic framework for.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
How and Why Drugs Work Chapter 5
Guidance for Industry M4S: The CTD-Safety
What risks do these pollutants pose to us? To determine this we need to understand the following.
Supercourse Environmental Exposure Assessment And Biomarkers Wael Al-Delaimy, MD, PhD.
Lecture #3 Hazards and their effects. Epidemiology = The study of the distribution and causes of disease and injuries in human populations. – Epidemiologists.
CVM’s Procedure for Setting Tolerances
Committee on Carcinogenicity (COC) Approach to Risk Assessment of Genotoxic Carcinogens David H. Phillips* COC Chairman Descriptive vs. Quantitative.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Toxicology Concepts.
TRAINING FOR THE HEALTH SECTOR
 Drinking-Water Standards  History  Key Definitions  How Standards are Developed  Current Issues Confronting Developers of Standards.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
An Overview of Nutrition
Biomedical Research Objective 2 Biomedical Research Methods.
Biomedical Research.
Chapter 20: Toxicity Testing. There are two purposes of toxicity testing. –There is a quantitative effort to elucidate a dose–effect relationship –There.
Environmental Hazards & Human Health
Environmental Hazards and Human Health Chapter 17.
Copyright © 2002 University of Maryland School of Nursing. All rights reserved. Comparison of Pharmacology and Toxicology This material was developed at.
Health Hazards Instructional Goal
Healthy Living.
Risk Assessment Nov 7, 2008 Timbrell 3 rd Edn pp Casarett & Doull 7 th Edn Chapter 7 (pp )
RISK ASSESSMENT. Major Issues to be considered in designing the Study 1.- Emission Inventory What is the relative significance of the various sources.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
What is Nutrition? The science of food, the nutrients and the substances therein, their action, interaction, and balance in relation to health and disease,
EHS 507 Potential dose: the amount of chemical that is ingested or inhaled, or the amount of chemical contained in material applied to skin. Applied dose:
Chapter 12 Nutrition Guidelines ©2015 Cengage Learning.
EHS 507 Food Exposures: Fruits and Vegetables  Fruits and vegetables may become contaminated by multiple pathways –Purposeful spraying or soil treatment.
Leading a Healthy Life. I. Health in the Past ► Infectious disease was the leading cause of death. ► People died from diseases such as the flu and bacterial.
Session VII WEIGHING IN ON MICROBIOLOGICAL ADI: EXPERIENCES AND PERSPECTIVES Introduction October 26, 2012.
Companion Animal Clinical Nutrition Chapter 15 Pages Please read pgs Stop at Nutrient Terms J. Melendez/2008.
Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Acute Toxicity Studies Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption,
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Students type their answers here
1 Risk Assessment for Air Toxics: The 4 Basic Steps NESCAUM Health Effects Workshop Bordentown, NJ July 30, 2008.
DOSE-RESPONSE ASSESSMENT
What are hazards in food system? Physical – Fish bones, nail, hair, etc… Chemical – Environmental pollutants Heavy metal Polymers – Pesticides – Antibiotic.
Understanding the Risk Assessment Process
Biologic Monitoring A. H. Mehrparvar, MD
Risk Assessment Dec 4 -6, 2006.
Introduction to Environmental Engineering and Science (3rd ed.)
REPRODUCTION REVIEW II
THE DOSE MAKES THE POISON
Biopharmaceutics Dr Mohammad Issa Saleh.
Risk Assessment Dec 7, 2009 Timbrell 3rd Edn pp 16-21
Leading a Healthy Life.
56 Nutrition.
Objective 2 Biomedical Research Methods
Understanding the Risk Assessment Process
What Is Nutrition? -The study of how your body uses the food that you eat.
VICH GL 54, Studies to evaluate the safety of residues of veterinary drugs in human food: General approach to establish an Acute Reference Dose (ARfD)
Presentation transcript:

MAIN TOXICITY TESTING

TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use in foods. These include: Consideration of the chemical structutre and any intended biological activity (e.g. anti-oxidant) In vitro models, such as cell cultures or tissue slices Laboratory animals Human volunteers

TOXICITY TESTS Acute oral toxicity - Single dose study to define extent of toxicity in absence of other data. Short-term toxicity - Repeated daily doses for days to provide indications of toxic potential.

TOXICITY TESTS Subchronic toxicity - Repeated daily doses for 90 days to provide information on major site(s) of toxicity and effects, and to indicate suitable dose levels for chronic studies, usually in two species, rodent and non-rodent. Chronic toxicity and carcinogenicity - Repeated daily doses for 2 years in rodents, providing the data most frequently used in deriving the ADI

TOXICITY TESTS Genetic toxicity - Short-termed tests for capacity to interact with DNA and to cause mutations or chromosome changes, using a variety of endpoints in bacterial and mammalian systems, in vitro and in vivo. Reproductive and developmental toxicity - Repeated daily doses before, during and after gestation to determine effects on male and female fertility and on the developing fetus and neonate and possible inheritable effects. Usually involves a multigeneration study in a rodent and developmental toxicity in two species.

TOXICITY TESTS Immunotoxicity - Investigations on the structure and function of the tissues and cells involved in the immune response (included in short-term and subchronic studies). Neurotoxicity - Investigations on the structure and function of the nervous system, and on behaviour (included in short-term and subchronic studies).

The fate of an ingested chemical in the body, possibly leading to toxicity

Stages of possible toxicity of an ingested substance Not bioavailable Chemical in food Modified by gastrointestinal secretion or microflora Ingestion Excretion Absorbed intact LIVER

Stages of possible toxicity of an ingested substance Interaction with cell constituents/cells Excretion Repair Reactive metabolites Circulatory system Unchanged Toxicity Stable metabolites Extrahepatic organs/systems (further metabolic activation and/or detoxication possible) LIVER Excretion

Variation and uncertainty Modern toxicity studies are conducted in laboratory animals (mostly rodents), which :  have been bred specifically for the purpose;  should be of a defined genetic strain, free of infectious agents;

Variation and uncertainty  maintained under strict conditions that control all aspects of their care, hygiene, caging and bedding, diet, drinking water purity, temperature, humidity, light cycles and atmospheric conditions.

Variation and uncertainty The environmental and genetic controls mean that the individual animals used in a toxicity test are very similar to each other and therefore respond to toxic insult in a relatively homogenous manner. This reduces the background variability and therefore increases the sensitivity of the study to identify if effects at low doses.

Variation and uncertainty This is necessary both for the ethical and legal requirements to minimize numbers of animals used in toxicity testing, and to ensure the highest standards of quality for toxicity studies. Statistically significant differences between effects of different doses can be seen using groups of small number of animals.

Variation and uncertainty  External factors include components of the diet and substances that humans are exposed to from the environment (shown in the table), which may vary considerably at different times for one individual.

Variation and uncertainty  The stages leading to possible toxicity of an ingested substance can be presented in a diagram:

EXTERNAL FACTORS THAT MAY INFLUENCE SUSCEPTIBILITY TO TOXICITY DIETARY FACTORS Alcohol Carbohydrates Essential elements Fat Protein Pyrolysis products (formed during cooking) Trace elements Vitamins ENVIRONMENTAL FACTORS Drugs of abuse Heavy metals Industrial pollutants Pesticides Petroleum products Pharmaceuticals Pyrolysis products (as pollutants) Tobacco smoke

Variations and uncertainty There are a number of uncertainties involved in extrapolation from a dose of chemical that have no effect in animals to a level of intake that will be safe to people. The sources of uncertainty in establishing Acceptable Daily Intake (ADI) can be presented in the following way: *ADI: an estimate of the amount of a food additive expressed on a body weight basis, that can be ingested daily over of lifetime without appreciable health risk

Variations and uncertainty  Animal to human extrapolation - Relationship of the NOAEL (No Observed Adverse Effect Level) to the threshold dose - Prediction of effects at low doses, based on studies conducted at high dose levels - Relevance to humans – interspecies differences

Variations and uncertainty Interindividual variability in human population - Internal – genetics, gender, disease status - External – nutrition, drugs, smoking, alcohol, environmental pollutants

Variations and uncertainty Because of these uncertainties, it is considered necessary to take a cautious approach, which assumes that people may be more sensitive to toxicity than laboratory animals, and therefore a margin of safety must be allowed.